20p12.3 Microdeletion Syndrome

External Ids:

ICD10 via Orphanet 33 Q93.5 Orphanet 58 ORPHA261295

SNOMED-CT via HPO 68 128613002 14582003 194021007 205101001 22006008 224958001 237836003 246545002 246800008 249321001 249773003 253366007 313307000 35045004 398151007 398152000 405752007 70142008 74390002 84757009 91175000 more

NIH Rare Diseases : ⁵² The following summary is from Orphanet , a European reference portal for information on rare diseases and orphan drugs. Orpha Number: 261295 Definition 20p12.3 microdeletion syndrome is a recently described syndrome characterized by Wolff-Parkinson-White syndrome (see this term), variable developmental delay and facial dysmorphism. Epidemiology It has been clinically and molecularly characterized in 3 patients. Clinical description Dysmorphic features include macrocephaly, hypertelorism, down-slanting palpebral fissures and microstomia. Etiology This syndrome is caused by an interstitial deletion encompassing 20p12.3. All these deletions except one occurred de novo and were characterized by comparative genomic hybridization (CGH) microarray and fluorescence in situ hybridization (FISH). They have a variable size with the smallest region of overlap including only one gene , BMP2 , which is a good candidate gene for explaining the phenotype of Wolff-Parkinson-White syndrome. Visit the Orphanet disease page for more resources.

MalaCards based summary : 20p12.3 Microdeletion Syndrome, is also known as monosomy 20p12.3. An important gene associated with 20p12.3 Microdeletion Syndrome is BMP2 (Bone Morphogenetic Protein 2). Related phenotypes are global developmental delay and hypertelorism

Search Clinical Trials , NIH Clinical Center for 20p12.3 Microdeletion Syndrome

Search GEO for disease gene expression data for 20p12.3 Microdeletion Syndrome.